Sequans Communications (SQNS) Regains NYSE Compliance

Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, announced today that it has regained compliance with the New York Stock Exchange (NYSE) continued listing standards.

"We are pleased to regain full compliance with the NYSE standards and appreciate the continued support of our investors and stakeholders as we focus on delivering value and strengthening our position as a technology leader," said Georges Karam, CEO of Sequans Communications. "We remain fully committed to executing our long-term strategy of driving innovation in the cellular IoT space and accelerating business growth."

On April 9, 2024, the NYSE notified Sequans of its non-compliance due to the Company's average global market capitalization falling below $50 million over a consecutive 30-trading-day period, while at the same time, its stockholders' equity was below $50 million. Additionally, the average closing price of the Company's American Depositary Shares (ADSs) was below $1.00 per share over a consecutive 30-trading-day period.

To address these deficiencies and restore compliance, Sequans took corrective actions, including adjusting the ratio of its ordinary shares represented by ADSs, effective October 9, 2024, and increasing its stockholders' equity and market capitalization following the $200 million strategic transaction that closed September 30, 2024. The change in exchange ratio had the same effect as a 1-for-2.5 reverse stock split of the ADSs, effectively increasing the trading price of the ADSs to meet NYSE listing requirements. The gains from the strategic transactions resulted in a significant increase in stockholders' equity.

Following these measures, the NYSE has confirmed that Sequans is now fully compliant with all applicable listing requirements.

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• NorthStrive files two patents for muscle-loss drugs in spaceflight
• Magna Holdings makes unsolicited bid for 31% of Yatra Online